Accessibility Menu
 
Scholar Rock logo

Scholar Rock

(NASDAQ) SRRK

Current Price$50.24
Market Cap$5.75B
Since IPO (2018)+223%
5 Year+7%
1 Year+54%
1 Month+13%

Scholar Rock Financials at a Glance

Market Cap

$5.75B

Revenue (TTM)

$0.00

Net Income (TTM)

$377.94M

EPS (TTM)

$-3.43

P/E Ratio

-14.60

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Price

$50.24

Volume

46,026

Open

$48.52

Previous Close

$50.24

Daily Range

$47.96 - $50.36

52-Week Range

$22.71 - $50.50

SRRK: Motley Fool Moneyball Superscore

67

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Scholar Rock

Industry

Biotechnology

Employees

289

CEO

David L. Hallal

Headquarters

Cambridge, MA 02142, US

SRRK Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-123%

Return on Capital

-1%

Return on Assets

-93%

Earnings Yield

-6.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.75B

Shares Outstanding

114.88M

Volume

46.03K

Short Interest

0.00%

Avg. Volume

1.34M

Financials (TTM)

Gross Profit

$1.66M

Operating Income

$384.64M

EBITDA

$369.39M

Operating Cash Flow

$300.04M

Capital Expenditure

$602.00K

Free Cash Flow

$300.64M

Cash & ST Invst.

$367.56M

Total Debt

$108.92M

Scholar Rock Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$425.00K

-7.6%

Gross Margin

0.00%

N/A

Market Cap

$5.75B

N/A

Market Cap/Employee

$44.89M

N/A

Employees

128

N/A

Net Income

$90.97M

-36.9%

EBITDA

$83.82M

-26.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$258.65M

-30.5%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$103.36M

+74.2%

Short Term Debt

$5.55M

-3.9%

Return on Assets

-93.49%

N/A

Return on Invested Capital

-1.10%

N/A

Free Cash Flow

$75.53M

-52.5%

Operating Cash Flow

$75.50M

-52.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CDTXCidara Therapeutics, Inc.
$221.38+0.00%
XENEXenon Pharmaceuticals Inc.
$56.85+0.28%
KNSAKiniksa Pharmaceuticals, Ltd.
$48.82+1.43%
LEGNLegend Biotech Corporation
$19.14+0.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About SRRK

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.